branded
-
Slow growth for branded prescriptions
Growth will slow to 1.3 percent in 2015 for the branded prescription pharmaceutical industry’s leading companies, according to Datamonitor. Between 2003 and 2009, theses same companies enjoyed robust sales growth at a compound annual growth rat…
branded | 01 March 2011
-
Branded Pharma Needs to Capitalize on Emerging Markets
With US$110 billion in global sales exposed to generic competition for the top 50 pharmaceutical companies through to 2014, branded pharma must look to emerging markets, biologics and continued cost-saving initiatives to drive growth according to Dat…
branded | 05 May 2010
-
Nycomed to Acquire Local Portfolio from Sanofi-Aventis and Zentiva
Nycomed has agreed with Sanofi-Aventis and Zentiva to purchase 20 branded generic products in several Central and Eastern European countries. The agreement will strengthen the former’s market position especially in the Czech Republic and Slova…
branded | 01 September 2009
-
UK Budget Heralds Price Cuts on Branded Pharmaceuticals
As part of the UK government’s drive to save £2.3 billion (US$3.4 billion) in the National Health Service (NHS) during 2010–11, £550m will be cut from the prices of branded drugs as a result of the revised Pharmaceutical Price Regulation Schem…
branded | 01 June 2009
